Gilead Sciences (GILD) Interest Coverage Ratio (2009 - 2026)
Gilead Sciences' (GILD) quarterly Interest Coverage Ratio came in at 10.78 in Q1 2026, up 25.23% YoY from 8.6 in Q1 2025, and up 38.49% on a QoQ basis from 7.78 in Q4 2025.
Gilead Sciences (GILD) Interest Coverage Ratio (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has 18 years of Interest Coverage Ratio data on file, last reported at 10.78 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 25.23% year-over-year to 10.78 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10.32 (up 20.25% YoY) and the FY2025 annual result came in at 5.6, up 371.36% from the prior year.
- Interest Coverage Ratio climbed to 10.78 in Q1 2026, from 7.78 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 13.0 in Q3 2025 to a low of 17.02 in Q1 2024.
- A 5-year average of 4.92 and a median of 7.78 in 2025 frame the typical range for Interest Coverage Ratio.
- The widest YoY moves for Interest Coverage Ratio: up 1493.35% in 2024, down 2473.22% in 2024.
- Tracing GILD's Interest Coverage Ratio over 5 years: stood at 11.45 in 2022, then slipped by 29.25% to 8.1 in 2023, then jumped by 35.74% to 11.0 in 2024, then decreased by 29.24% to 7.78 in 2025, then surged by 38.49% to 10.78 in 2026.
- The last three Interest Coverage Ratio figures came in at 10.78 (Q1 2026), 7.78 (Q4 2025), and 13.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | - |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 10.28 |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 7.27 |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 5.22 |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -42.08 |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | -2.64 |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | -50.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -42.08 |
| Mar 31, 2026 | 10.78 |
| Dec 31, 2025 | 7.78 |
| Sep 30, 2025 | 13.00 |
| Jun 30, 2025 | 9.74 |
| Mar 31, 2025 | 8.60 |
| Dec 31, 2024 | 11.00 |
| Sep 30, 2024 | 3.73 |
| Jun 30, 2024 | 11.16 |
| Mar 31, 2024 | -17.02 |
| Dec 31, 2023 | 8.10 |
| Sep 30, 2023 | 1.10 |
| Jun 30, 2023 | 0.70 |
| Mar 31, 2023 | 0.72 |
| Dec 31, 2022 | 11.45 |
| Sep 30, 2022 | 1.60 |
| Jun 30, 2022 | 1.15 |
| Mar 31, 2022 | 0.11 |
| Dec 31, 2021 | 3.95 |
| Sep 30, 2021 | 2.18 |